A Phase 1, Multicenter, Open-label, Dose-escalation, Combination Study of Marizomib and Bevacizumab in Bevacizumab-Naïve Subjects with WHO Grade IV Malignant Glioma followed by a Phase 2 Trial of Single Agent Marizomib

UCI-14-58
NCT02330562
Cancer - Brain and Nervous System
Daniela Bota
Open
Treatment
Avastin, Bevacizumab, Marizomib
I
Adult
Local

For information about cancer clinical trials at the UC Irvine Health Chao Family Comprehensive Cancer Center, call toll-free 877-UC-STUDY (877-827-8839) or email ucstudy@uci.edu.